Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Working mechanism of immunoglobulin A1 (IgA1) protease: cleavage of IgA1 antibody to Neisseria meningitidis PorA requires de novo synthesis of IgA1 Protease.
Vidarsson G, Overbeeke N, Stemerding AM, van den Dobbelsteen G, van Ulsen P, van der Ley P, Kilian M, van de Winkel JG. Vidarsson G, et al. Among authors: van der ley p, van den dobbelsteen g, van ulsen p, van de winkel jg. Infect Immun. 2005 Oct;73(10):6721-6. doi: 10.1128/IAI.73.10.6721-6726.2005. Infect Immun. 2005. PMID: 16177349 Free PMC article.
Relative immunogenicity of PorA subtypes in a multivalent Neisseria meningitidis vaccine is not dependent on presentation form.
Luijkx TA, van Dijken H, Hamstra HJ, Kuipers B, van der Ley P, van Alphen L, van den Dobbelsteen G. Luijkx TA, et al. Among authors: van alphen l, van der ley p, van dijken h, van den dobbelsteen g. Infect Immun. 2003 Nov;71(11):6367-71. doi: 10.1128/IAI.71.11.6367-6371.2003. Infect Immun. 2003. PMID: 14573657 Free PMC article.
Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesicles.
Zariri A, van Dijken H, Hamstra HJ, van der Flier M, Vidarsson G, van Putten JP, Boog CJ, van den Dobbelsteen G, van der Ley P. Zariri A, et al. Among authors: van putten jp, van der ley p, van dijken h, van der flier m, van den dobbelsteen g. Vaccine. 2013 Nov 12;31(47):5585-93. doi: 10.1016/j.vaccine.2013.07.069. Epub 2013 Aug 6. Vaccine. 2013. PMID: 23933369
Immunogenicity studies with a genetically engineered hexavalent PorA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys.
Rouppe van der Voort E, Schuller M, Holst J, de Vries P, van der Ley P, van den Dobbelsteen G, Poolman J. Rouppe van der Voort E, et al. Among authors: van der ley p, van den dobbelsteen g. Vaccine. 2000 Jan 31;18(14):1334-43. doi: 10.1016/s0264-410x(99)00402-8. Vaccine. 2000. PMID: 10618530
Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine.
Vermont CL, van Dijken HH, van Limpt CJ, de Groot R, van Alphen L, van Den Dobbelsteen GP. Vermont CL, et al. Among authors: van limpt cj, van alphen l, van den dobbelsteen gp, van dijken hh. Infect Immun. 2002 Feb;70(2):584-90. doi: 10.1128/IAI.70.2.584-590.2002. Infect Immun. 2002. PMID: 11796586 Free PMC article. Clinical Trial.
Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine.
Vermont CL, van Dijken HH, Kuipers AJ, van Limpt CJ, Keijzers WC, van der Ende A, de Groot R, van Alphen L, van den Dobbelsteen GP. Vermont CL, et al. Among authors: van limpt cj, van alphen l, van den dobbelsteen gp, van der ende a, van dijken hh. Infect Immun. 2003 Apr;71(4):1650-5. doi: 10.1128/IAI.71.4.1650-1655.2003. Infect Immun. 2003. PMID: 12654777 Free PMC article. Clinical Trial.
75 results